Methods to Enhance AZR-MD-001 for Meibomian Gland Dysfunction (MGD)
Clinical trial NCT04314362 · COMPLETED
Trial details
- NCT number
- NCT04314362
- Sponsor
- Azura Ophthalmics
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-07-14
- Primary completion
- 2021-01-06
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.